Significance of plasma adiponectin for diagnosis, neurological severity and functional outcome in ischemic stroke - Research for Biomarkers in Ischemic Stroke (REBIOS)

Article ID	Journal	Published Year	Pages	File Type
5903366	Metabolism	2014	46 Pages	PDF

Abstract

Plasma adiponectin values may help to classify stroke subtypes and predict neurological severity and functional outcome in ischemic stroke patients.

Keywords

ChF trial of org 10172 in acute stroke treatment NIHSS IQR MRS LAC adiponectin MRI standard deviation Lacunar infarction Magnetic resonance imaging TOAST computed tomography standard error Stroke subtype Metabolic syndrome Ischemic stroke confidence interval Atrial fibrillation Low density lipoprotein-cholesterol High density lipoprotein-cholesterol METS interquartile range Modified Rankin scale National Institute of Health Stroke Scale Chronic heart failure Functional outcome odds ratio Biomarkers HDL-cholesterol LDL-cholesterol

Related Topics

Life Sciences Biochemistry, Genetics and Molecular Biology Endocrinology

Preview

Significance of plasma adiponectin for diagnosis, neurological severity and functional outcome in ischemic stroke - Research for Biomarkers in Ischemic Stroke (REBIOS)

Authors

Takahiro Kuwashiro, Tetsuro Ago, Masahiro Kamouchi, Ryu Matsuo, Jun Hata, Junya Kuroda, Kenji Fukuda, Hiroshi Sugimori, Masayo Fukuhara, Hideto Awano, Tetsu Isomura, Kazuo Suzuki, Masahiro Yasaka, Yasushi Okada, Yutaka Kiyohara, Takanari Kitazono,